VERU Quick Ratio | VERU INC.

VERU INC. Quick Ratio

The quick ratio is a stricter test of whether a company can pay the bills due within a year, counting only assets that are already cash or close to it. It is cash, marketable securities and receivables divided by current liabilities, shown as a multiple, with both amounts in the table. It is the current ratio with inventory and other assets that take longer to turn into cash removed, so it is never higher than the current ratio. A company that does not report one of the inputs has no point for that date rather than an estimated one. Quarterly points use quarter-end balances; annual points use fiscal-year-end balances.

VERU INC. quick ratio for the quarter ending 2026-06-30 was 3.88, a 72.69% increase year-over-year.
VERU INC. quick ratio for the quarter ending 2026-03-31 was 5.12, a 43.75% increase year-over-year.
VERU INC. quick ratio for the quarter ending 2025-12-31 was 4.63, a 10.44% increase year-over-year.
VERU INC. quick ratio for the quarter ending 2025-09-30 was 2.03, a 16.62% decline year-over-year.
VERU INC. quick ratio for fiscal 2025 was 2.03, a 16.62% decline from fiscal 2024.
VERU INC. quick ratio for fiscal 2024 was 2.43, a 206.65% increase from fiscal 2023.
VERU INC. quick ratio for fiscal 2023 was 0.79.
VERU INC. quick ratio for fiscal 2015 was 4.31, a 66.45% increase from fiscal 2014.

Available history: 2010-09-30 to 2026-06-30
Data captured: 2026-06-30

Historical Quick Ratio

Date	Quick Ratio	Quick assets	Current liabilities
2026-06-30	3.88	$23.88M	$6.16M
2026-03-31	5.12	$27.6M	$5.39M
2025-12-31	4.63	$32.99M	$7.13M
2025-09-30	2.03	$15.79M	$7.79M
2025-06-30	2.25	$15.01M	$6.68M
2025-03-31	3.56	$20.02M	$5.62M
2024-12-31	4.19	$26.61M	$6.35M
2024-09-30	2.43	$28.88M	$11.87M
2024-06-30	2.9	$30.79M	$10.62M
2023-09-30	0.79	$14.13M	$17.81M
2015-12-31	4.77	$21.36M	$4.48M
2015-09-30	4.31	$18.19M	$4.23M
2015-06-30	3.68	$16.96M	$4.61M
2015-03-31	3.32	$15.41M	$4.65M
2014-12-31	3.02	$10.4M	$3.45M
2014-09-30	2.59	$8.74M	$3.38M
2014-06-30	2.82	$9.56M	$3.39M
2014-03-31	1.64	$8.42M	$5.13M
2013-12-31	2.18	$10.66M	$4.89M
2013-09-30	3.26	$11.28M	$3.47M
2013-06-30	2.67	$12.86M	$4.82M
2013-03-31	2.16	$13.59M	$6.29M
2012-12-31	2.15	$12.17M	$5.65M
2012-09-30	2.14	$12.56M	$5.86M
2012-06-30	2.54	$13.03M	$5.13M
2012-03-31	2.15	$10.74M	$5M
2011-12-31	2.41	$9.45M	$3.93M
2011-09-30	2.86	$6.56M	$2.29M
2011-06-30	3.08	$4.62M	$1.5M
2010-09-30	3.81	$7.38M	$1.94M

Annual Quick Ratio

Date	Quick Ratio	Quick assets	Current liabilities
2025-09-30	2.03	$15.79M	$7.79M
2024-09-30	2.43	$28.88M	$11.87M
2023-09-30	0.79	$14.13M	$17.81M
2015-09-30	4.31	$18.19M	$4.23M
2014-09-30	2.59	$8.74M	$3.38M
2013-09-30	3.26	$11.28M	$3.47M
2012-09-30	2.14	$12.56M	$5.86M
2011-09-30	2.86	$6.56M	$2.29M
2010-09-30	3.81	$7.38M	$1.94M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Kairos Pharma, LTD. (KAPA)	United States	$0.041B
SCYNEXIS INC (SCYX)	United States	$0.045B
PDS Biotechnology Corp (PDSB)	United States	$0.045B
Incannex Healthcare Inc. (IXHL)		$0.040B	-22.32
Grace Therapeutics, Inc. (GRCE)		$0.046B	-1.83
Karyopharm Therapeutics Inc. (KPTI)	United States	$0.039B	-0.98
Edesa Biotech, Inc. (EDSA)	Canada	$0.039B
Werewolf Therapeutics, Inc. (HOWL)	United States	$0.047B
CervoMed Inc. (CRVO)	United States	$0.038B	-1.39
Celularity Inc (CELU)	United States	$0.038B	-0.34